Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM Program.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM Program.
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM Program. Eur J Heart Fail. 2006 Mar; 8(2):191-7.
View in:
PubMed
subject areas
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Aorta
Benzimidazoles
Biphenyl Compounds
Blood Pressure
Capillary Resistance
Cardiac Output
Chronic Disease
Compliance
Female
Follow-Up Studies
Heart Failure
Humans
Male
Middle Aged
Multivariate Analysis
Prospective Studies
Pulsatile Flow
Stroke Volume
Tetrazoles
Treatment Outcome
Ventricular Function, Left
authors with profiles
Terrence X. O'Brien